Thomas Siegemund

Thomas Siegemund

Auto-generated profile, based on publicly available information

Thomas Siegemund

Universität Leipzig

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Thrombosis Research
Verified
Journal Article
Closed access
Yesim DargaudYesim Dargaud
Yesim Dargaud
RLR. Luddington
R. Luddington
EGE. Gray
E. Gray
TLT. Lecompte
T. Lecompte
TST. Siegemund
T. Siegemund
CNC. Negrier
C. Negrier

1 January 2003 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
TSThomas Siegemund
Thomas Siegemund
ASAnnelie Siegemund
Annelie Siegemund
USUte Scholz
Ute Scholz
LELothar Engelmann
Lothar Engelmann
SPSirak Petros
Sirak Petros
Summary: Thrombin generation was investigated in platelet-rich plasma (PRP) from 11 healthy controls, 17 patients with severe haemophilia A and 7 patients with severe haemophilia B. Mean endogenous thrombin potential (ETP) in arbitrary fluorescence units (FU) was 226.9 ± 44.6, 186.4 ± 22.5, 154.2 ± 41.3 in controls, haemophilia A and B, respectively, all at a platelet count of 200 × 109/l (p = 0.004 for controls vs.haemophilia A, p = 0.003 for controls vs. haemophilia B, no significant difference between haemophilia A and B). The contribution of FVIII to thrombin generation in haemophilia A was 1.31 ± 0.16 FU/% of FVIII:C activity , while for FIX in haemophilia B this was 0.80 ± 0.21 FU/% of FIX activity. There was an almost linear relationship between increasing platelet count and thrombin generation up to a mean platelet count of 100 × 109/l. Further increase in platelet count has only a marginal influence on thrombin generation. Platelets increase ETP in haemophilia A by 0.184 ± 0.022 FU/109platelets/l and in haemophilia B by 0.319 ± 0.085 FU/109platelets/l, and this was significantly different between the two groups (p = 0.0002). This influence of platelets diminishes with increasing concentration of either FVIII or FIX. In conclusion, there is a difference in thrombin generation between haemophilia A and B, and this may be attributed to the role of platelets in the assembly of the tenase complex on their surface.

28 December 2005 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
TST. Siegemund
T. Siegemund
BPB.‐R. Paulke
B.‐R. Paulke
HSH. Schmiedel
H. Schmiedel
NBNatalie Bordag
Natalie Bordag
AHA. Hoffmann
A. Hoffmann
WHW. Härtig
W. Härtig

18 November 2005 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
JBJ. Berrouschot
J. Berrouschot
BSB. Schwetlick
B. Schwetlick
GTG. Twickel
G. Twickel
CFC. Fischer
C. Fischer
HUH. Uhlemann
H. Uhlemann
ARA. Roessler
A. Roessler
Background – We investigated the platelet function in stroke patients treated with aspirin [acetylsalicylic acid (ASA)] for secondary stroke prevention during a follow‐up period of 1 year. Methods – In this prospective study 291 patients with first initiated aspirin therapy (300 mg/day) for secondary stroke prevention were included. Platelet aggregation measurements were performed 24 h, 3, 6, and 12 months after starting medication. Results – Twenty‐one of 291 patients (7.2%) were identified as primary ASA‐non‐responders (initial insufficient platelet inhibition) and 4.1% as secondary ASA‐non‐responders (insufficient platelet inhibition during follow‐up). There were no significant differences between ASA‐responders and ASA‐non‐responders concerning age, gender, risk factors, and stroke characteristics. Conclusion – Aspirin resistance in stroke patients is not uncommon. The clinical usefulness of routine platelet function tests needs to be proved by further trials.

1 June 2012 in Thrombosis Research
Verified
Journal Article
Closed access
SPS. Petros
S. Petros
PKP. Kliem
P. Kliem
TST. Siegemund
T. Siegemund
RSR. Siegemund
R. Siegemund

1 January 2014 in Hamostaseologie
Verified
Journal Article
Closed access
PDF file
USU. Scholz
U. Scholz
RSR. Schobess
R. Schobess
TST. Siegemund
T. Siegemund
ASA. Siegemund
A. Siegemund
Summary: Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. Patients, method: In this study the feasibility of clot waveform analysis for monitoring of haemophilia A was investigated using blood samples from healthy controls as well as haemophilia A patients under various clinical conditions. Results: Thrombin, prothrombinase and tenase activity show a high correlation to factor VIII levels. Tenase activity was found to exhibit a linear relationship to factor VIII levels over a very large concentration range and was able to discriminate patients with severe, moderate and mild haemophilia. Conclusion: Clot waveform analysis is an easy, fast and cheap method to access disturbances in clot formation and can be done without any additional measurements beside an aPTT.